Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival

Annals of Oncology

Volumn 10, Issue 6, 1999, Pages 707-713

  Smith, K ^a   Fox, S B ^a   Whitehouse, R ^a   Taylor, M ^a   Greenall, M ^a   Clarke, J ^a   Harris, A L ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Fibroblast growth factor; Microvasculature

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; ESTROGEN RECEPTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; CARCINOGENESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032818363     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008303614441     Document Type: Article

References (47)

1. Folkman J. What is the evidence that tumours are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4-6.
2. Gasparini G, Harris AL. Clinical importance of the determination of tumour angiogenesis in breast carcinoma: Much more than a new prognostic tool. J Clin Oncol 1995; 13: 765-82.
3. Rice G, Bevilacqua M. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 1988; 246: 1303-6.
4. Horak E, Leek R, Klenk N et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as an indicator of node, metastasis and survival in breast cancer. Lancet 1992; 340: 1120-4.
5. Bosari S, Lee A, Delellis R et al. Microvessel quantitation and prognosis in invasive breast carcinoma. Human Pathol 1992; 23: 755-61.
6. Weidner N, Semple JP, Welch WR, Folkman J. Tumour angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
7. Weidner N, Folkman J, Puzza F et al. Tumour angiogenesis: A new significant and independent prognostic indicator in early stage breast carcinoma. J Natl Cancer Inst 1992; 84: 1875-87.
8. Scott PAE, Harris AL. Current approaches to targeting cancer using antiangiogenic therapies. Cancer Treat Rev 1994; 20: 393-412.
9. Saksela O, Moscatelli D, Sommer A, Rifkin D. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol 1988; 107: 743-51.
10. Baird A, Ling N. Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: Implications for a role of heparinase-like enzymes in the neovascular response. Biochem Biophys Res Comm 1987; 142: 428-35.
11. Bashkin P, Doctrow S, Klagsbrun M et al. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 1989; 28: 1737 43.
12. Kandel J, Bossy WE, Radvanyi F et al. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 1991; 66: 1094-104.
13. Jackson A, Friedman S, Zhan X et al. Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc Natl Acad Sci 1992; 89: 10691 5.
14. Dickson C, Smith R, Brookes S, Peters G. Tumorigenesis by mouse mammary tumour virus: Proviral activation of a cellular gene in the common integration region int 2. Cell 1984; 37: 529-36.
15. Murakami A, Tanake H, Matsuzawa A. Association of hst gene expression with metastatic phenotype in mouse mammary tumours. Cell Growth Differentiation 1990; 1: 225-31.
16. Jaye M, Lyall RM, Schlessinger J, Sarver N. Expression of acidic fibroblast growth factor cDNA confers growth advantage and tumorigenesis to Swiss 3T3 cells. EMBO J 1988; 7: 963-9.
17. Neufeld G, Mitchell R, Ponte P, Gospodarowicz D. J Cell Biol 1988; 106: 1385-94.
18. McLeskey SW, Kurebayashi J, Honig SF et al. Fibroblast growth factor 4 transfection of MCF-7 cell lines that are tumorigenic and metastatic in ovariectomised or tamoxifen-treated athymic nude mice. Cancer Res 1993; 53: 2168-77.
19. Nanus DM, SchmitzDrager BJ, Motzer RJ et al. Expression of basic fibroblast growth factor in primary human renal tumours: Correlation with poor survival. J Natl Cancer Inst 1993; 85: 1597-99.
20. Nguyen M, Watanabe H, Budson A et al. Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J Natl Cancer Inst 1993; 85: 241-2.
21. Folkman J. Tumour angiogenesis: Diagnostic and therapeutic clinical implications. Am Assoc Cancer Res 1993; 34: 571-2.
22. Elston C. Grading of invasive carcinoma of the breast. In Page D, Anderson T (eds): Diagnostic Histopathology of the Breast. Edinburgh: Churchill Livingstone 1987; 300-11.
23. Bradford MM. A rapid and sensitive method for the quantitation of protein utilising the principle of protein dye binding. Anal Biochem 1976; 72: 248 54.
24. Nicholson S, Sainsbury JRC, Needham GK et al. Quantitative assays of epidermal growth factor in human breast cancer: Cut off points of clinical relevance. Int J Cancer 1988; 42: 36-41.
25. Fox SB, Leek RD, Smith K et al. Tumour angiogenesis in node negative breast carcinoma-relationship to epidermal growth factor receptor, estrogen receptor and survival. Breast Cancer Res Treat 1994; 29: 109-16.
26. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
27. O'Neill JS, Elton RA, Miller WR. Aromatase activity in adipose tissue from breast quadrants: A link with tumour site. BMJ Clin Res ED 1988; 296: 741-3.
28. Smith HS, Lu Y, Deng G et al. Molecular aspects of early stages of breast cancer progression. J Cell Biochem 1993; 17G (Suppl): 144-52.
29. Eguchi J, Nomata K, Kanda S et al. Gene expression and immunohistochemical localization of basic fibroblast growth factor in renal cell carcinoma. Biochem Biophys Res Comm 1992; 183: 937-44.
30. Takahashi JA, Mori H, Fukumot, M et al. Gene expression of fibroblast growth factors in human gliomas and meningiomas: Demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumour tissues. Proc Natl Acad Sci 1990; 87: 5710-4.
31. Luqmani YA, Graham M, Coombes RC. Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. Br J Cancer 1992; 66: 273 80.
32. Annandappa SY, Winstanley JHR, Leinster S et al. Comparilive expression of fibroblast growth factor mRNAs in benign and malignant breast disease. Br J Cancer 1994; 69: 772-6.
33. Epner DE, Partin AW, Schalken JA et al. Association of glyceraldehyde-3-phosphate dehydrogenase expression with cell motility and metastatic potential of rat prostatic adenocarcinoma. Cancer Res 1993; 53: 1995-7.
34. Graven KK, Troxler RF, Kornfeld H et al. Regulation of endothelial cell glyceraldehyde-3-phosphate dehydrogenase expression by hypoxia. J Biol Chem 1994; 269: 24446-53.
35. Meyer SK, Rahman MN, Wurzer JC, Sirover MA. Prolifrative dependent regulation of the glyceraldehyde-3-phosphate dehydrogenase-uracil DNA glycosylase gene in human cells. Carcinogenesis 1992; 13: 2127-32.
36. Mansur NR, Meyer SK, Wurzer JC, Sirover MA. Cell cycle regulation of the glyceraldehyde-3-phosphate dehydrogenase/ uracil DNA glycosylase gene in normal human cell. Nucleic Acids Res 1993; 21: 993 8.
37. Scott PAE, Smith K, Bicknell R, Harris AL. A reliable external control for ribonuclease protection assays. Nucleic Acids Res 1997; 25: 1305-6.
38. Florkiewicz RZ, Baird A, Gonzalez AM. Multiple forms of bFGF: Differential nuclear and cell surface localization. Growth Factors 1991; 4: 265-75.
39. Estival A, Monzat V, Miquel K et al. Differential regulation of fibroblast growth factor (FGF) receptor-1 mRNA and protein by two molecular forms of basic FGF. Modulation of FGFR-1 mRNA stability. J Biol Chem 1996; 271: 5663-70.
40. Arnaud E, Touriol C, Boutonnet C et al. A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor. Mol Cell Biol 1999; 19: 505-14.
41. O'Brien T, Cranston D, Fuggle S et al. Two mechanisms of basic fibroblast growth factor induced angiogenesis in bladder cancer. Cancer Res 1997; 57: 136-40.
42. Coope RC, Browne PJ, Yiangou C et al. The location of acidic fibroblast growth factor in breast is dependent on the activity of proteases present in breast cancer tissue. Br J Cancer 1997; 75: 1621-30.
43. Colomer R, Aparicio J, Montero S et al. Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma. Br J Cancer 1997; 76: 1215 20.
44. Yiangou C, Gomm JJ, Coope RC et al. Fibroblast growth factor 2 in breast cancer: Occurrence and prognostic significance. Br J Cancer 1997; 75: 28-33.
45. Winstanley J, Annandappa S, Green B et al. Acid and basic fibroblast growth factors and their relationship to vascular density. Eur J Cancer 1994; 30A: S6.
46. Nguyen MHW, Budson A, Richie JP et al. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 1994; 86: 356-61.
47. Blanckaert VD, Hebbar M, Louchez MM et al. Basic fibroblast growth factor receptors and their prognostic value in human breast cancer. Clin Cancer Res 1998; 4: 2939-47.